𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A four-kallikrein panel for the prediction of repeat prostate biopsy: data from the European Randomized Study of Prostate Cancer Screening in Rotterdam, Netherlands

✍ Scribed by Gupta, A; Roobol, M J; Savage, C J; Peltola, M; Pettersson, K; Scardino, P T; Vickers, A J; Schröder, F H; Lilja, H

Book ID
110000604
Publisher
Nature Publishing Group
Year
2010
Tongue
English
Weight
432 KB
Volume
103
Category
Article
ISSN
0007-0920

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictors for biopsy outcome in the Eur
Predictors for biopsy outcome in the European Randomized Study of Screening for Prostate Cancer (Rotterdam Region)
✍ Kranse, Ries; Beemsterboer, Petra; Rietbergen, John; Habbema, Dik; Hugosson, Jon 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 2 views

In the European Randomized Study of Screening for Prostate Cancer (ER-SPC, Rotterdam region), men aged 55-74 years are screened for prostate cancer by prostatespecific antigen (PSA) sampling, digital rectal examination (DRE), and transrectal ultrasound investigation (TRUS). All men with a PSA Ն4 ng/

Impact of recent screening on predicting
Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen : Data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden
✍ Andrew J. Vickers; Angel M. Cronin; Gunnar Aus; Carl-Gustav Pihl; Charlotte Beck 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 266 KB 👁 2 views

## Abstract ## BACKGROUND: Risk models to predict prostate cancer on biopsy, whether they include only prostate‐specific antigen (PSA) or other markers, are intended for use in all men of screening age. However, the association between PSA and cancer probably depends on a man's recent screening hi

Changing role of 3 screening modalities
Changing role of 3 screening modalities in the European randomized study of screening for prostate cancer (Rotterdam)
✍ P.M.M. Beemsterboer; R. Kranse; H.J. de Koning; J.D.F. Habbema; F.H. Schröder 📂 Article 📅 1999 🏛 John Wiley and Sons 🌐 French ⚖ 88 KB 👁 2 views

A randomized screening trial was started in Europe to show the effect of early detection and treatment of prostate cancer on mortality (European Study on Screening of Prostate Cancer). In one centre (Rotterdam), the screening protocol initially consisted of 3 screening tests for all men: prostate-sp

Effective PSA contamination in the Rotte
Effective PSA contamination in the Rotterdam section of the European Randomized Study of Screening for Prostate Cancer
✍ Suzie J. Otto; Ingrid W. van der Cruijsen; Michael K. Liem; Ida J. Korfage; Jan 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 French ⚖ 93 KB 👁 2 views

## Abstract The extent of effective prostate‐specific antigen (PSA) contamination in the Rotterdam section of the ongoing European Randomized Study of Screening for Prostate Cancer (ERSPC) trial was evaluated and defined as when opportunistic PSA testing of ≥ 3.0 ng/ml was followed by biopsy, simil